The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy and safety of olverembatinib (HQP1351) as second-line therapy in patients with chronic-phase chronic myeloid leukemia (CP-CML).
 
Weiming Li
No Relationships to Disclose
 
Yanli Zhang
No Relationships to Disclose
 
Huanling Zhu
No Relationships to Disclose
 
Yunfan Yang
No Relationships to Disclose
 
Na Xu
No Relationships to Disclose
 
Bingcheng Liu
No Relationships to Disclose
 
Zi Chen
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Wei Chu
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Yifan Zhai
Leadership - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Yu Hu
No Relationships to Disclose